{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:02Z","timestamp":1791357482941,"version":"4.3.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.pnpbp.2017.07.019","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T15:00:15Z","timestamp":1500994815000},"page":"452-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Antipsychotics for aggression in adults: A meta-analysis"],"prefix":"10.1016","volume":"81","author":[{"given":"Gerrit I.","family":"van Schalkwyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Deal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2017.07.019_bb0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0924-977X(01)00097-9","article-title":"Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials","volume":"11","author":"Aleman","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s002130050064","article-title":"Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment","volume":"148","author":"Allain","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1176\/appi.ajp.2010.10040569","article-title":"Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study","volume":"168","author":"Allen","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1819.2008.01790.x","article-title":"Predictors of violent behavior among acute psychiatric patients: clinical study","volume":"62","author":"Amore","year":"2008","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0025","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1176\/jnp.9.4.591","article-title":"Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease","volume":"9","author":"Auchus","year":"1997","journal-title":"J, Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0030","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/bmj.38369.459988.8F","article-title":"Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial","volume":"330","author":"Ballard","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0035","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.pneurobio.2010.08.007","article-title":"Nucleus accumbens and impulsivity","volume":"92","author":"Basar","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0040","series-title":"Comprehensive Meta Analysis","author":"Biostat","year":"2016"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v66n0116","article-title":"A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder","volume":"66","author":"Bowden","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4088\/JCP.v64n0205","article-title":"A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia","volume":"64","author":"Brodaty","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0055","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1176\/appi.ajp.2012.11101529","article-title":"Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia","volume":"169","author":"Brodaty","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0060","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1126\/science.8211186","article-title":"Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A","volume":"262","author":"Brunner","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0065","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.7792602","article-title":"Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA","volume":"268","author":"Cases","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/S1092852915000310","article-title":"Serotonin and impulsive aggression","volume":"20","author":"Coccaro","year":"2015","journal-title":"CNS Spect."},{"issue":"Suppl. 3","key":"10.1016\/j.pnpbp.2017.07.019_bb0075","first-page":"309","article-title":"Conceptualization of agitation: results based on the Cohen-Mansfield Agitation Inventory and the Agitation Behavior Mapping Instrument","volume":"8","author":"Cohen-Mansfield","year":"1996","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0080","doi-asserted-by":"crossref","DOI":"10.1377\/hlthaff.28.5.w770","article-title":"Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges","volume":"28","author":"Crystal","year":"2009","journal-title":"Health Aff."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00004714-199508000-00002","article-title":"Effect of risperidone on hostility in schizophrenia","volume":"15","author":"Czobor","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000118170","article-title":"The effect of milenperone on the aggressive behavior of oligophrenic patients. A double-blind placebo-controlled study","volume":"13","author":"De Cuyper","year":"1985","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0095","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1212\/WNL.53.5.946","article-title":"A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia","volume":"53","author":"De Deyn","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0193-953X(05)70321-X","article-title":"Psychopharmacologic treatment of pathologic aggression","volume":"20","author":"Fava","year":"1997","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1098-2337(1990)16:3\/4<259::AID-AB2480160311>3.0.CO;2-Z","article-title":"Regional serotonin and dopamine activity: sensitivity to amphetamine and aggressive behavior in mice","volume":"16","author":"Haney","year":"1990","journal-title":"Aggress. Behav."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0115","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1176\/appi.ajp.2007.06101710","article-title":"Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications","volume":"164","author":"Kales","year":"2007","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0120","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.57.6.553","article-title":"A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy","volume":"57","author":"Kapur","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v60n0207","article-title":"Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group","volume":"60","author":"Katz","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2008.05.014","article-title":"Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study","volume":"112","author":"Keck","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2017.07.019_bb0135","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0140","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.bcp.2015.07.019","article-title":"Modulation of aggressive behavior in mice by nicotinic receptor subtypes","volume":"97","author":"Lewis","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0145","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0150","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4088\/JCP.v58n1205","article-title":"The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials","volume":"58","author":"Marder","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0155","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.55.7.633","article-title":"A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders","volume":"55","author":"McDougle","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0160","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.euroneuro.2005.02.006","article-title":"Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial","volume":"15","author":"McIntyre","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0165","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.paid.2006.06.004","article-title":"Reactive and proactive aggression: similarities and differences","volume":"41","author":"Miller","year":"2006","journal-title":"Personal. Individ. Differ."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00004714-200304000-00012","article-title":"Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder","volume":"23","author":"Monnelly","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0175","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrn2174","article-title":"Neural mechanisms of aggression","volume":"8","author":"Nelson","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0180","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1176\/ajp.2006.163.5.833","article-title":"Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study","volume":"163","author":"Nickel","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0185","doi-asserted-by":"crossref","DOI":"10.1007\/s10803-016-2890-6","article-title":"Brief report: initial trial of alpha7-nicotinic receptor stimulation in two adult patients with autism spectrum disorder","author":"Olincy","year":"2016","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0190","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/gps.1892","article-title":"Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study","volume":"23","author":"Paleacu","year":"2008","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-1781(94)90093-0","article-title":"Psychometric properties of the Postive and Negative Syndrome Scale (PANSS) in schizophrenia","volume":"53","author":"Peralta","year":"1994","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0200","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.159.3.460","article-title":"Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients","volume":"159","author":"Pollock","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0205","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881106059693","article-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study","volume":"20","author":"Sachs","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0210","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1126\/science.8091214","article-title":"Enhanced aggressive behavior in mice lacking 5-HT1B receptor","volume":"265","author":"Saudou","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0220","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.avb.2008.06.003","article-title":"Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders","volume":"13","author":"Seo","year":"2008","journal-title":"Aggress. Violent Behav."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0225","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00008877-200006000-00011","article-title":"Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice","volume":"11","author":"Spielewoy","year":"2000","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0230","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.avb.2003.08.005","article-title":"Cognitive-behavioral therapy for anger in children and adolescents: a meta-analysis","volume":"9","author":"Sukhodolsky","year":"2004","journal-title":"Aggress. Violent Behav."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13210","article-title":"Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID)","volume":"13","author":"Tyrer","year":"2009","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0240","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1007\/s10803-015-2471-0","article-title":"Reduction of aggressive episodes after repeated transdermal nicotine administration in a hospitalized adolescent with autism spectrum disorder","volume":"45","author":"Van Schalkwyk","year":"2015","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0245","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00004583-199703000-00008","article-title":"Subtypes of aggression and their relevance to child psychiatry","volume":"36","author":"Vitiello","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0250","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0255","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/bjp.bp.108.049965","article-title":"Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study","volume":"194","author":"Young","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.07.019_bb0260","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/156720507779939805","article-title":"Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study","volume":"4","author":"Zhong","year":"2007","journal-title":"Curr. Alzheimer Res."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617303160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617303160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T20:24:49Z","timestamp":1535574289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584617303160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":52,"alternative-id":["S0278584617303160"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.07.019","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotics for aggression in adults: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}